Re: Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?

Authors :: Clare Allen
Rhys Ball
Shonit Punwani
Mark Emberton
Vasilis Stavrinides
Caroline M. Moore
Clement Orczyk
Aiman Haider
Francesco Giganti
Hayley C. Whitaker
Alex Kirkham
Alex Freeman
Source :: Journal of Urology. 204:1065-1066
Publication Year :: 2020
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2020.

Subjects :: Male
business.industry
Urology
Visibility (geometry)
Prostatic Neoplasms
medicine.disease
Prostate cancer
medicine
Humans
Multiparametric Magnetic Resonance Imaging
Neoplasm Grading
business
Nuclear medicine

Full Text Access

Tools